As of Jun 29
| -0.72 / -13.56%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +771.46% increase from the last price of 4.59.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.